Blocking type i interferon (IFN) signaling impairs antigen responsiveness of circulating lymphocytes and alters their homing to lymphoid organs: Protective role of type i IFN

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 1029-1040

  Badr, Gamal ^a,b,c   Waly, Hanan ^a   Saad Eldien, Heba M ^d   Abdel Tawab, Hanem ^a   Hassan, Khadega ^a   Alhazza, Ibrahim M ^b,c   Ebaid, Hossam ^c   Alwasel, Saleh H ^b,c  

^a Assiut University   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Assiut University Faculty of Medicine   (Egypt)

Author keywords

Anti IFNR1; Apoptosis; B Lymphocytes; Lymphoid Tissues; Proliferation; T Lymphocytes; Type I IFN

Indexed keywords

INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROTECTION; CELL ULTRASTRUCTURE; CIRCULATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PEYER PATCH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN; THYMUS;

ANIMALIA; MUS;

EID: 78651260887     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323978     Document Type: Article

References (49)

1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
2. Regan RF, Panter SS, Witz A, Tilly JL, Giffard RG: Ultrastructure of excitotoxic neuronal death in murine cortical culture. Brain Research 1995;705:188-198.
3. Ihara T, Yamamoto T, Sugamata, M, Okumura H, Ueno Y: The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch 1998;433:443-447.
4. Seymour R, Sundberg J P, Hogenesch H: Abnormal lymphoid organ development in immunodeficient mutant mice. Vet Pathol 2006;43:401-423.
5. Ehrchen JM, Roth J, Roebrock K, Varga G, Domschke W, Newberry R, Sorg C, Müller-Tidow C, Sunderkötter C, Kucharzik T, Spahn TW: The Absence of Cutaneous Lymph Nodes Results in a Th2 Response and Increased Susceptibility to Leishmania major Infection in Mice. Infect Immun 2008;76:4241-4250.
6. Pabst O, Herbrand H, Bernhardt G, Förster R: Elucidating the functional anatomy of secondary lymphoid organs. Curr Opin Immunol 2004;16:394-399.
7. Li ZF, Zhang S, Lv GB, Huang Y, Zhang W, Ren S, Yang J, Dang SS: Changes in count and function of splenic lymphocytes from patients with portal hypertension. World J Gastroenterol 2008;14:2377-2382.
8. Tsunoda I, Libbey JE, Kuang LQ, Terry EJ, Fujinami RS: Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis. Am J Pathol 2005;167:1631-1646.
9. Oritani K, Kincade PW, Zhang C, Tomiyama Y, Matsuzawa Y: Type I in-terferon and limitin: a coparision of structures, receptors, and functions. Cytokine Growth Factor Rev 2001;12:337-348.
10. Bach, EA, Aguet M, Schreiber RD: The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997;15:563-591.
11. Heim MH: The Jak-STAT pathway: cytokine signaling from the receptor to the nucleus. J Receptor Signal Transduc Res 1999;19:75-120.
12. Deonarain R, Chan DC, Platanias LC, Fish EN: Interferon-alpha-receptor interactions: A complex story unfolding. Curr Pharm Des 2002;8:2131-2137.
13. Lamken P, Lata S, Gavutis M, Piehler J: Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J Mol Biol 2004;341:303-318.
14. Claudinon J, Gonnord P, Beslard E, Marchetti M, Mitchell K, Boularan C, Johannes L, Eid P, Lamaze C: Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha. J Biol Chem 2009;284:24328-24340.
15. Van den Broek MF, Mûller U, Huang S, Zinkernagel RM, Aguet M: Immune defense in mice lacking type I and/or type II interferon receptors. Immunol Rev 1995;148:5-18. (Pubitemid 26010539)
16. Badr G, Saad H, Waly H, Hassan K, Abdel-Tawab H: Type I interferon (IFN-alpha/ beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL). Cellular Immunol 2010;263:31-40.
17. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U, Swedenborg J: Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 2003;38:1283-1292.
18. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT: Immunohistochemical analyses of estrogen receptor in endometrial adeno-carcinoma using a monoclonal antibody. Cancer Res 1986;46:5419-5425.
19. Murray MJ, Zhang J, Lessey BA: Expression of a6 and b4 integrin subunits throughout the menstrual cycle: no correlation with uterine receptivity. Fertil Steri 1999;72:522-526.
20. Gupta PD: Ultrastructural study on Semithin section. Science Tools 1983;30:6-7.
21. Drury R, Wallington EA: Carleton's his-tological techniques. 5th ed, Oxford University Press, 1980.
22. Nicole A, de Weerd SA, Samarajiwa, Paul JH: Type Interferon Receptors: Biochemistry and Biological Functions. J Biol Chem 2007;28:20053-20057.
23. Marijanovic Z, Ragimbeau J, Van Heyden J, Uzé G, Pellegrini S: Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J 2007;407:141-151.
24. Sheehan KC, Lai KS, Dunn GP: Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Inter-feron Cytokine Res 2006;26:804-819.
25. Okkenhaug K, Vanhaesebroeck B: PI3K in lymphocyte development, differentiation and activation. Nat Rev Immuno 2003;3:317-330.
26. Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B, Schreiber RD, Hertzog P, Smyth MJ: Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol 2007;178:7540-7549.
27. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J: Induction of dendritic cell differentiation by IFN-α in systemic lupuerythematosus. Science 2001;294:1540-1543.
28. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5:1249-1255.
29. Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, Fukuhar S: Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 2001;166:2961-2969.
30. Tough DF, Borrow P, Sprent J: Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996;272:1947-1950. (Pubitemid 26234507)
31. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K: Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005;202:637-650.
32. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, Rossmann C, Kalinke U, Tough DF: Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 2006;176:4682-4689.
33. Marrack P, Kappler J, Mitchell T: Type I interferons keep activated T cells alive. J Exp Med 1999;189:521-530.
34. Havenar-Daughton C, Kolumam GA, Murali-Krishna K: Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 2006;176:3315-3319.
35. Banchereau J, Brière F, Liu YJ, Rousset F: Molecular control of B lymphocyte growth and differentiation. Stem Cells 1994;12:278-288.
36. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TC: Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology 1996;42:69-78.
37. Badr G, Borhis G, Treton D, Richard Y: IFN-alpha enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and inter-nalization. Int Immunol 2005;17:459-467.
38. Wang J, Lin Q, Langston H, Cooper MD: Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunit 1995;3:475-484.
39. Lin Q, Dong C, Cooper MD: Impairment of T and B cell development by treatment with a type I interferon. J Exp Med 1998;187:79-87.
40. Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG: Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemo-taxis and homing. J Immunol 2004;173:2236-2240.
41. Girard JP, Springer TA: High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol 1995;16:449-457.
42. Forster R, Schubel A, Breitfeld D: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lym-phoid organs. Cell 1999;99:23-33.
43. Erdem A, Sevgili AM, Akbiyik F: Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture. J Surg Res 2007;141:211-219.
44. Sastre J, Pallardo F V, Vina J: Mitochon-drial oxidative stress plays a key role in aging and apoptosis. Life 2000;49:427-435.
45. Bernardi P, Scorrano L, Colonna R, Petronilli V, Lisa FD: Mitochondria and cell death. Eur J Biochem 1999;264:687-701.
46. Brajuskovic GR., Skaro-Milic AB, Marjanovic SA, Cerovic SJ, Knezevic-Usaj SF: The ultrastructural investigation of mitochondria in B-CLL cells during apoptosis. Arch Oncol 2004;12:139-141.
47. Houwerzijl EJ, Blom NR, Want JJd, Esselink MT, Koornstra JJ, Smit JW, Louwes H, Vellenga E, de Wolf JT: Ul-trastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 2004;103:500-506.
48. Asher E, Payne CM, Bernstein C: Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electro-phoresis, light microscopy and electron microscopy. II. Induction of non-classic apoptosis ("para-apoptosis") by tritiated thymidine. Leuk Lymphoma 1995;19:107-119.
49. Vakifahmetoglu H, Olsson M, Zhivotovsky B: Death through a tragedy: mitotic catastroph. Cell Death Differ 2008;15:1153-1162.